X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (310) 310
Publication (13) 13
Patent (8) 8
Book Chapter (2) 2
Book Review (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (117) 117
male (82) 82
female (75) 75
middle aged (75) 75
surgery (68) 68
medicine & public health (64) 64
cancer (60) 60
index medicus (59) 59
aged (57) 57
esophageal cancer (55) 55
surgical oncology (55) 55
oncology (53) 53
thoracic surgery (44) 44
gastroenterology & hepatology (36) 36
gastroenterology (30) 30
treatment outcome (29) 29
biochemistry & molecular biology (27) 27
prognosis (27) 27
carcinoma (26) 26
adult (25) 25
molecular sequence data (25) 25
aged, 80 and over (22) 22
animals (22) 22
base sequence (22) 22
cardiac surgery (22) 22
chemotherapy (21) 21
metastasis (21) 21
esophageal neoplasms - surgery (20) 20
esophageal neoplasms - pathology (19) 19
esophagectomy (19) 19
saccharomyces cerevisiae - genetics (19) 19
amino acid sequence (18) 18
care and treatment (18) 18
yeast (18) 18
medical colleges (17) 17
retrospective studies (17) 17
cell biology (16) 16
gastric cancer (16) 16
lymphatic metastasis (16) 16
saccharomyces cerevisiae - metabolism (16) 16
analysis (15) 15
carcinoma, squamous cell - pathology (15) 15
squamous cell carcinoma (15) 15
stomach neoplasms - pathology (15) 15
stomach neoplasms - surgery (15) 15
abdominal surgery (14) 14
esophagus (14) 14
japan (14) 14
neoplasm invasiveness (14) 14
polymerase chain reaction (14) 14
saccharomyces cerevisiae proteins (14) 14
saccharomyces cerevisiae proteins - metabolism (14) 14
saccharomyces-cerevisiae (14) 14
stomach cancer (14) 14
immunohistochemistry (13) 13
mutation (13) 13
radiotherapy (13) 13
survival analysis (13) 13
combined modality therapy (12) 12
complex (12) 12
gene expression (12) 12
health aspects (12) 12
proteins (12) 12
squamous-cell carcinoma (12) 12
survival rate (12) 12
time factors (12) 12
cardiology (11) 11
esophageal neoplasms - mortality (11) 11
fungal proteins - genetics (11) 11
neoplasm staging (11) 11
saccharomyces cerevisiae - enzymology (11) 11
survival (11) 11
trial (11) 11
vascular surgery (11) 11
dna (10) 10
esophageal neoplasms - radiotherapy (10) 10
esophageal neoplasms - therapy (10) 10
pathology (10) 10
research (10) 10
risk factors (10) 10
tumors (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
cancer patients (9) 9
carcinoma, squamous cell - therapy (9) 9
chemoradiotherapy (9) 9
endoscopy (9) 9
esophageal carcinoma (9) 9
expression (9) 9
follow-up studies (9) 9
gastrectomy - methods (9) 9
liver neoplasms - secondary (9) 9
mammary adenocarcinoma (9) 9
mice (9) 9
overexpression (9) 9
recurrence (9) 9
resection (9) 9
saccharomyces cerevisiae proteins - genetics (9) 9
adenocarcinoma - surgery (8) 8
antimitotic agents (8) 8
antineoplastic agents (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical & Experimental Metastasis, ISSN 0262-0898, 3/2009, Volume 26, Issue 3, pp. 215 - 227
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2008, Volume 9, Issue 3, pp. 215 - 221
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 07/2014, Volume 105, Issue 7, pp. 812 - 817
This multicenter phase II study first investigated the efficacy and safety of nanoparticle albumin‐bound paclitaxel ( nab ‐paclitaxel) when given every 3 weeks... 
phase | paclitaxel | triweekly | Gastric cancer | nab | second‐line chemotherapy | Second-line chemotherapy | nab-paclitaxel | Phase II | Triweekly | PLUS CISPLATIN | CREMOPHOR-FREE | second-line chemotherapy | ARBEITSGEMEINSCHAFT INTERNISTISCHE ONKOLOGIE | SALVAGE CHEMOTHERAPY | phase II | SUPPORTIVE CARE | ONCOLOGY | COMPARING IRINOTECAN | COMBINATION CHEMOTHERAPY | 1ST-LINE THERAPY | SOLVENT-BASED PACLITAXEL | Humans | Middle Aged | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Paclitaxel - adverse effects | Male | Stomach Neoplasms - pathology | Treatment Outcome | Stomach Neoplasms - drug therapy | Paclitaxel - therapeutic use | Albumins - therapeutic use | Disease-Free Survival | Antineoplastic Agents, Phytogenic - administration & dosage | Albumins - adverse effects | Leukopenia - chemically induced | Adult | Female | Aged | Antineoplastic Agents, Phytogenic - therapeutic use | Neutropenia - chemically induced | Stomach Neoplasms - mortality | Antineoplastic Agents, Phytogenic - adverse effects | Antimitotic agents | Relapse | Chemotherapy | Clinical trials | Albumin | Product development | Antineoplastic agents | Stomach cancer | Diseases | Cancer | Breast cancer | Metastasis | Neuropathy | Cancer therapies | Disease control | Survival | Blood | Nanoparticles | Lymphopenia | Paclitaxel | Drug dosages | Neutropenia | Pharmaceuticals | Index Medicus | Original
Journal Article
Cancer Science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 407 - 412
Low‐dose cisplatin and 5‐fluorouracil (LDPF) chemotherapy with daily radiotherapy (RT) is used as an alternative chemoradiotherapy regimen for locally advanced... 
toxicity | esophageal squamous cell carcinoma | Chemoradiotherapy | randomized trial | survival | Esophageal squamous cell carcinoma | Randomized trial | Toxicity | Survival | ONCOLOGY-GROUP | PHASE-II | LUNG-CANCER | 5-FLUOROURACIL | CISPLATIN | ONCOLOGY | HYPERFRACTIONATED RADIATION | CONTINUOUS-INFUSION | RADIOTHERAPY | DEFINITIVE CHEMORADIOTHERAPY | CONCURRENT CHEMORADIOTHERAPY | Chemoradiotherapy - adverse effects | Chemoradiotherapy - methods | Humans | Middle Aged | Carcinoma, Squamous Cell - therapy | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Esophageal Neoplasms - radiotherapy | Lymphatic Metastasis | Carcinoma, Squamous Cell - radiotherapy | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Esophageal Neoplasms - therapy | Dose-Response Relationship, Radiation | Esophageal Neoplasms - drug therapy | Esophageal Squamous Cell Carcinoma | Medical research | Esophageal carcinoma | Lymphatic system | Squamous cell carcinoma | Research & development--R&D | Clinical trials | Metastasis | Radiation therapy | Contact angle | Cancer therapies | Patients | Cisplatin | Lymph nodes | Esophagus | Metastases | Chemotherapy | Medical prognosis | Esophageal cancer | Tumors | Index Medicus | Original
Journal Article
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 04/2010, Volume 15, Issue 2, pp. 126 - 134
Both cigarette smoking and alcohol drinking are well-established risk factors for esophageal squamous cell carcinoma (ESCC), and the relationship of dose to... 
Drinking | Multiple cancers | Aldehyde dehydrogenase | Esophageal cancer | Smoking | RISK-FACTORS | THORACIC ESOPHAGUS | SERIAL HISTOLOGIC EVALUATION | UPPER AERODIGESTIVE TRACT | JAPANESE ALCOHOLICS | ONCOLOGY | P53 PROTEIN ACCUMULATION | MULTICENTRIC OCCURRENCE | ALDEHYDE DEHYDROGENASE-2 GENOTYPE | MULTIPLE OCCURRENCE | ACETALDEHYDE CONCENTRATION | Esophageal Neoplasms - etiology | Smoking - adverse effects | Predictive Value of Tests | Aldehyde Dehydrogenase, Mitochondrial | Carcinoma, Squamous Cell - genetics | Humans | Esophageal Neoplasms - prevention & control | Male | Case-Control Studies | Esophageal Neoplasms - epidemiology | Esophagoscopy | Carcinoma, Squamous Cell - diagnosis | Esophageal Neoplasms - diagnosis | Female | Odds Ratio | Flushing - etiology | Genetic Predisposition to Disease | Risk Assessment | Carcinoma, Squamous Cell - epidemiology | Early Detection of Cancer | Risk Factors | Aldehyde Dehydrogenase - genetics | Carcinoma, Squamous Cell - prevention & control | Alcohol Drinking - adverse effects | Polymorphism, Genetic | Carcinoma, Squamous Cell - etiology | Animals | Esophageal Neoplasms - genetics | Alcohol Drinking - epidemiology | Smoking - epidemiology | Prevention | Medical research | Squamous cell carcinoma | Medicine, Experimental | Drinking of alcoholic beverages | Health aspects | Epidemiology | Acetaldehyde | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 10/2017, Volume 108, Issue 10, pp. 2045 - 2051
A phase II study of S‐1 plus leucovorin ( LV ) given in a 4‐week schedule (2 weeks’ administration followed by 2 weeks’ rest) for patients with untreated... 
pharmacokinetics | Clinical trial | S‐1 (combination) | leucovorin | colorectal neoplasms | S-1 (combination) | ORAL LEUCOVORIN | BEVACIZUMAB | COMBINATION THERAPY | OXALIPLATIN | TOXICITY | ANTITUMOR-ACTIVITY | FLUOROURACIL | SUPPORTIVE CARE | 5-FLUOROURACIL | ONCOLOGY | URACIL/TEGAFUR | Anorexia - epidemiology | Leucovorin - administration & dosage | Neutropenia - epidemiology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Diarrhea - epidemiology | Male | Diarrhea - chemically induced | Neoplasm Metastasis | Leucovorin - adverse effects | China | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Stomatitis - epidemiology | Oxonic Acid - pharmacokinetics | Neutropenia - chemically induced | Drug Administration Schedule | Japan | Tegafur - adverse effects | Treatment Outcome | Oxonic Acid - administration & dosage | Tegafur - pharmacokinetics | Leucovorin - pharmacokinetics | Oxonic Acid - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Survival Analysis | Tegafur - administration & dosage | Anorexia - chemically induced | Aged | Drug Combinations | Antimitotic agents | Cancer patients | Care and treatment | Oncology, Experimental | Colorectal cancer | Diarrhea | Clinical trials | Leucovorin | Metastasis | Research | Antineoplastic agents | Cancer | Anorexia | Colorectal carcinoma | Cytotoxicity | Cancer therapies | Disease control | Survival | Metastases | Studies | Stomatitis | Chemotherapy | Response rates | Clinical medicine | Pharmacokinetics | Drug dosages | Neutropenia | Pharmaceuticals | Tumors | Index Medicus | Original
Journal Article